|
COPYRIGHT 2005 The Dallas Morning News
Byline: Jim Landers
Oct. 28--WASHINGTON -- All across the country, healthy but anxious Americans are asking their doctors for Tamiflu. They fear an epidemic of lethal bird flu, and the remedy is in short supply.
Should we hoard it? Should the makers sell or give away the formula? Should the intellectual property behind a lifesaving product like Tamiflu be taken from its owners?
Those questions are ricocheting around the world right now. Hoffman-LaRoche Ltd., the Swiss maker of Tamiflu, halted U.S. deliveries Wednesday because large buyers seemed to be hoarding supplies and cutting into what is available for treating regular influenza victims. Roche said deliveries would resume when seasonal flu cases increase.
The anxiety over bird flu is so acute that a World Health Organization expert warned this week that European governments might have to station troops to protect Tamiflu supplies....
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
